1. AstraZeneca quits cancer pipeline efforts — Eisai's weight loss drug is pulled from market due to safety concerns — Melinta seeks buyout bids to escape bankruptcy — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Celltech

Anonymous board for Celltech


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    0
    Views:
    3,323
  2. Anonymous
    Replies:
    3
    Views:
    2,580
  3. Anonymous
    Replies:
    2
    Views:
    3,636
  4. Anonymous
    Replies:
    3
    Views:
    4,097
  5. Anonymous
    Replies:
    12
    Views:
    4,380
  6. Anonymous
    Replies:
    7
    Views:
    4,093

Thread Display Options

Loading...